1. The risks of tienilic acid do not warrant its use

   Newsletter Article 29 January 2013 Pages: 1 - 1

2. Call for child-proof containers for methadone

   Newsletter Article 29 January 2013 Pages: 1 - 1

3. Immunosuppressive therapy increases malignancy risk

   Newsletter Article 29 January 2013 Pages: 1 - 1

4. Upjohn may be sued by UK triazolam users

   Newsletter Article 29 January 2013 Pages: 2 - 2

5. Call to limit Japanese encephalitis vaccine use

   Newsletter Article 29 January 2013 Pages: 3 - 3

6. The USA should review their position on medroxyprogesterone

   Newsletter Article 29 January 2013 Pages: 3 - 3

7. Anticonvulsants

   Newsletter Article 29 January 2013 Pages: 3 - 3

8. Antineoplastics

   Newsletter Article 29 January 2013 Pages: 3 - 3

9. Baclofen

   Newsletter Article 29 January 2013 Pages: 3 - 4

10. Bamipine

    Newsletter Article 29 January 2013 Pages: 4 - 4

11. Buserelin

    Newsletter Article 29 January 2013 Pages: 4 - 4

12. Ceftazidime

    Newsletter Article 29 January 2013 Pages: 4 - 4

13. Chloroquine overdose

    Newsletter Article 29 January 2013 Pages: 4 - 4

14. Clenbuterol

    Newsletter Article 29 January 2013 Pages: 4 - 4

15. Cyclosporin

    Newsletter Article 29 January 2013 Pages: 4 - 5

16. Dexamethasone see Phenytoin interaction

    Newsletter Article 29 January 2013 Pages: 5 - 5

17. Diphtheria, pertussis and tetanus vaccine

    Newsletter Article 29 January 2013 Pages: 5 - 5

18. Gammaglobulin

    Newsletter Article 29 January 2013 Pages: 5 - 5

19. Gemfibrozil

    Newsletter Article 29 January 2013 Pages: 5 - 5

20. Heparin

    Newsletter Article 29 January 2013 Pages: 5 - 5

21. Hydrocortisone see Methylprednisolone/hydrocortisone

    Newsletter Article 29 January 2013 Pages: 5 - 5

22. Hypoglycaemics

    Newsletter Article 29 January 2013 Pages: 5 - 5

23. Interferon alpha/interferon alpha 2A/interferon alpha 2B

    Newsletter Article 29 January 2013 Pages: 5 - 5

24. Interferon alpha 2A see Interferon alpha/interferon alpha 2A/interferon alpha 2B

    Newsletter Article 29 January 2013 Pages: 6 - 6

25. Interferon alpha 2B see Interferon alpha/interferon alpha 2A/interferon alpha 2B

    Newsletter Article 29 January 2013 Pages: 6 - 6

26. Interferon beta

    Newsletter Article 29 January 2013 Pages: 6 - 6

27. Levodopa withdrawal

    Newsletter Article 29 January 2013 Pages: 6 - 6

28. Medroxyprogesterone

    Newsletter Article 29 January 2013 Pages: 6 - 6

29. Methylprednisolone/hydrocortisone

    Newsletter Article 29 January 2013 Pages: 6 - 6

30. Oral contraceptives

    Newsletter Article 29 January 2013 Pages: 6 - 6

31. Phenytoin

    Newsletter Article 29 January 2013 Pages: 6 - 6

32. Phenytoin interaction

    Newsletter Article 29 January 2013 Pages: 6 - 6

33. Proflavine

    Newsletter Article 29 January 2013 Pages: 6 - 7

34. Propantheline overdose

    Newsletter Article 29 January 2013 Pages: 7 - 7

35. Ranitidine

    Newsletter Article 29 January 2013 Pages: 7 - 7

36. RU 28318

    Newsletter Article 29 January 2013 Pages: 7 - 7

37. Simvastatin

    Newsletter Article 29 January 2013 Pages: 7 - 7

38. Spironolactone

    Newsletter Article 29 January 2013 Pages: 7 - 7

39. Sulpiride

    Newsletter Article 29 January 2013 Pages: 7 - 7

40. Tamoxifen

    Newsletter Article 29 January 2013 Pages: 7 - 8

41. Teicoplanin

    Newsletter Article 29 January 2013 Pages: 8 - 8

42. Theophylline

    Newsletter Article 29 January 2013 Pages: 8 - 8

43. Thiamazole

    Newsletter Article 29 January 2013 Pages: 8 - 8

44. Tranylcypromine abuse

    Newsletter Article 29 January 2013 Pages: 8 - 8

45. Triazolam

    Newsletter Article 29 January 2013 Pages: 8 - 8

46. Tryptophan

    Newsletter Article 29 January 2013 Pages: 8 - 8

47. Vigabatrin

    Newsletter Article 29 January 2013 Pages: 8 - 8

48. Vincristine

    Newsletter Article 29 January 2013 Pages: 8 - 8

49. Zidovudine

    Newsletter Article 29 January 2013 Pages: 8 - 8